IN.PACT AV access randomized trial: Japan cohort outcomes through 12 months.

Hiroaki Haruguchi Kotaro Suemitsu Naoko Isogai Masaaki Murakami Masahiko Fujihara Kazuhiro Iwadoh Jeremiah MenkHiroko OokuboTomonari Ogawanull null

Published in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2023)

In this post hoc analysis of Japanese participants from the IN.PACT AV Access trial, participants treated with DCB had higher TLPP through 6 and 12 months compared with PTA.

Keyphrases

study protocol
clinical trial
phase iii
phase ii
randomized controlled trial
type diabetes
metabolic syndrome
open label
weight loss
insulin resistance